Immo-Pharm SRL
The score of Immo-Pharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +19 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Immo-Pharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 16,580 € | ||||
| Equity | 102,580 € | ||||
| Cash | 11,530 € | ||||
| EBITDA | 37,985 € | ||||
| Total assets | 498,245 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 23 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Immo-Pharm's financial analysis
- Solvency20.6%sector median: 18.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Immo-Pharm
Immo-Pharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0726.954.523
- VAT number
- BE0726954523
- Peppol
- Registered · 0208:0726954523 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 May 2019
- Registered office
- 1040 Etterbeek
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Immo-Pharm (SRL) has been based in Etterbeek since 2019, active in: buying and selling of own real estate. For 2025, it reports a net profit of 16,580 € and equity of 102,580 €; its revenue is not published. Its solvency stands at 20.6%, above the median of its sector (18.6%).
Companies similar to Immo-Pharm
Companies in the same business, of comparable size and area, outside its group.
- DAN Thana Non-specialised wholesale trade Ixelles · balance sheet 498,243 €
- LES Autos D'Isidore Manufacture of lighting equipment Momignies · balance sheet 498,408 €
- Centre Medical DE LA Foret General medical practice activities Brussels · balance sheet 497,842 €
- Livemont Denis Lessines · balance sheet 498,259 €
- Valcken Londerzeel · balance sheet 498,504 €
Frequently asked questions about Immo-Pharm
What is the revenue of Immo-Pharm?
Immo-Pharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Immo-Pharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0726954523 for Immo-Pharm, if the company is VAT-registered. Its company number (CBE) is 0726.954.523.
Where is the registered office of Immo-Pharm?
According to the CBE register, the registered office of Immo-Pharm is in 1040 Etterbeek.
What is the equity of Immo-Pharm?
At the close of the 2025 financial year, the equity of Immo-Pharm amounts to 102,580 €, a solvency of 20.6% of total assets.
Who manages Immo-Pharm?
The register lists 1 active mandates at Immo-Pharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Immo-Pharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →